Target intelligence / Profile preview

Cytokine (inflammation-modulating) (null)

Target
null
Molecular classification
Other (Secreted signaling protein)
01

Overview

Cytokines involved in inflammation modulation comprise a diverse family of secreted proteins—including interleukins, tumor necrosis factors, interferons, chemokines, and growth factors—that coordinate immune cell signaling and control both the induction and resolution of inflammation. Pro-inflammatory cytokines (such as IL-1, IL-6, TNF-α, IFN-γ) drive immune activation, fever, and tissue response to infection or injury, while anti-inflammatory cytokines (such as IL-10, IL-4, TGF-β) counteract these processes to prevent excessive damage and to promote tissue repair. The balance between these cytokines underlies the pathogenesis and therapy of many immune-mediated diseases and is the focus of major drug development efforts.

Other names
CytokinesInflammatory cytokinesAnti-inflammatory cytokinesPro-inflammatory cytokines
02

Mechanism of action

Neutralization of specific cytokines by monoclonal antibodies (e.g., anti-TNF, anti-IL-6) Inhibition or modulation of cytokine receptor signaling Blocking cytokine-receptor interactions Modulating transcription of cytokine genes

03

Biological functions

Immune responseInflammation regulation (promotion and resolution)Cell signalingCell proliferation and differentiationApoptosis (some cytokines)
04

Disease associations

InflammationAutoimmune diseaseCancerInfectionChronic pain syndromesOther (broad variety of immune-mediated diseases)
05

Safety considerations

Increased risk of infection due to immune suppressionCytokine release syndrome (CRS) with some immunomodulatory therapiesOff-target immune effects/pro-inflammatory or autoimmune complications
06

Interacting drugs

Monoclonal antibodies (e.g., adalimumab, infliximab for TNF-α; tocilizumab for IL-6)

2 more in the full profile.

07

Biomarkers

Serum levels of specific cytokines (e.g., IL-6, TNF-α, IL-1β)Cytokine panels for diagnosis and therapy monitoring in inflammatory diseases

Beyond the preview

Go deeper on Cytokine (inflammation-modulating) (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cytokine (inflammation-modulating) (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call